Oncolytic virotherapy for renal cell carcinoma: A novel treatment paradigm? - Abstract

Published on 03 September 2012

INTRODUCTION:Despite the development of novel targeted therapies, metastatic renal cell carcinoma (mRCC) remains an incurable disease.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.

Tags:

Search

Comments (0)

Only registered users can write comments!

Powered by Compojoom comment 4.2.1

Renal Cancer

<a href='http://ads.urotoday.com/www/delivery/ck.php?n=a1716eb4&cb={random}' target='_blank'><img src='http://ads.urotoday.com/www/delivery/avw.php?zoneid=118&cb={random}&n=a1716eb4' border='0' alt='' /></a>

Copyright © 2002 - 2013 Digital Science Press, Inc.

website design firm : Web-JIVE LLC